Highly tunable thiosulfonates as a novel class of cysteine protease inhibitors with anti-parasitic activity against Schistosoma mansoni

被引:9
|
作者
Ward, D. J. [1 ]
Van de langemheen, H. [1 ]
Koehne, E. [2 ]
Kreidenweiss, A. [2 ]
Liskamp, R. M. J. [1 ]
机构
[1] Univ Glasgow, Sch Chem, Joseph Black Bldg,Univ Ave, Glasgow G12 8QQ, Lanark, Scotland
[2] Univ Tubingen, Inst Trop Med, Wilhelmstr 27, D-72074 Tubingen, Germany
关键词
Thiosulfonate; Cysteine protease inhibitor; Schistosomiasis; Tunable electrophilic trap; Docking study; SELECTIVE INHIBITORS; S-NITROSYLATION; POTENT; CRUZAIN; IMMUNOPROTEASOME; OPTIMIZATION; DEGRADATION; HEMOGLOBIN; MECHANISM; RHODESAIN;
D O I
10.1016/j.bmc.2019.05.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The development of a new class of cysteine protease inhibitors utilising the thiosulfonate moiety as an SH specific electrophile is described. This moiety has been introduced into suitable amino acid derived building blocks, which were incorporated into peptidic sequences leading to very potent i.e. sub micromolar inhibitors of the cysteine protease papain in the same range as the vinyl sulfone based inhibitor K11777. Therefore, their inhibitory effect on Schistosoma mansoni, a human blood parasite, that expresses several cysteine proteases, was evaluated. The homophenylalanine side chain containing compounds 27-30 and especially 36 showed promising activities compared with K11777 and warrant further investigations of these peptidic thiosulfonate inhibitors as new potential anti-parasitic compounds.
引用
收藏
页码:2857 / 2870
页数:14
相关论文
共 5 条
  • [1] Role of T lymphocytes and papain enzymatic activity in the protection induced by the cysteine protease against Schistosoma mansoni in mice
    Tallima, Hatem
    Abou El Dahab, Marwa
    El Ridi, Rashika
    JOURNAL OF ADVANCED RESEARCH, 2019, 17 : 73 - 84
  • [2] Vaccines against parasitic diseases:: intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes anti-parasitic and anti-pathological immunity in mice
    Sun, JB
    Mielcarek, N
    Lakew, M
    Holmgren, J
    Czerkinski, C
    Grzych, JM
    Capron, A
    10TH INTERNATIONAL CONGRESS ON IMMUNOLOGY, VOLS 1 AND 2, 1998, : 1427 - 1430
  • [3] A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants
    Perez-Vargas, Jimena
    Worrall, Liam J.
    Olmstead, Andrea D.
    Ton, Anh-Tien
    Lee, Jaeyong
    Villanueva, Ivan
    Thompson, Connor A. H.
    Dudek, Svenja
    Ennis, Siobhan
    Smith, Jason R.
    Shapira, Tirosh
    De Guzman, Joshua
    Gang, Shutong
    Ban, Fuqiang
    Vuckovic, Marija
    Bielecki, Michael
    Kovacic, Suzana
    Kenward, Calem
    Hong, Christopher Yee
    Gordon, Danielle G.
    Levett, Paul N.
    Krajden, Mel
    Leduc, Richard
    Boudreault, Pierre-Luc
    Niikura, Masahiro
    Paetzel, Mark
    Young, Robert N.
    Cherkasov, Artem
    Strynadka, Natalie C. J.
    Jean, Francois
    EMERGING MICROBES & INFECTIONS, 2023, 12 (02)
  • [4] Fluorine Modifications Contribute to Potent Antiviral Activity against Highly Drug-Resistant HIV-1 and Favorable Blood-Brain Barrier Penetration Property of Novel Central Nervous System-Targeting HIV-1 Protease Inhibitors In Vitro
    Amano, Masayuki
    Yedidi, Ravikiran S.
    Salcedo-Gomez, Pedro Miguel
    Hayashi, Hironori
    Hasegawa, Kazuya
    Martyr, Cuthbert D.
    Ghosh, Arun K.
    Mitsuya, Hiroaki
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (02)
  • [5] Novel Protease Inhibitors Containing C-5-Modified bis-Tetrahydrofuranylurethane and Aminobenzothiazole as P2 and P2′ Ligands That Exert Potent Antiviral Activity against Highly Multidrug-Resistant HIV-1 with a High Genetic Barrier against the Emergence of Drug Resistance
    Takamatsu, Yuki
    Aoki, Manabu
    Bulut, Haydar
    Das, Debananda
    Amano, Masayuki
    Sheri, Venkata Reddy
    Kovari, Ladislau C.
    Hayashi, Hironori
    Delino, Nicole S.
    Ghosh, Arun K.
    Mitsuya, Hiroaki
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (08)